MURR Research and Development
University of Missouri-Columbia homepage    University of Missouri-Columbia
MURR Introduction to the nation's premier university research reactor MURR Research and Development--R&D at the nation's premier university research reactor MURR Education--training tomorrow's nuclear scientists, engineers and technicians MURR Products and Services--providing quality nuclear products and services to a global community MURR Operations--safe and reliable MURR Research Opportunities for MU faculty and students
return to Operations main page

MURR's Role in the fight against cancer
and other diseases with radiopharmaceuticals
With its beryllium and graphite-reflected core and flux of 6 x 1014 n/(cm2 sec), MURR can produce the needed flow of neutrons to make even minute amounts of "target" material highly radioactive in a precisely controlled manner. This pure, highly concentrated sample of radionuclide can be attached to the guiding biomolecule, often using another molecule as a go-between—a kind of "super glue." Upon injection into the patient, the biomolecule seeks out the tumors, bringing along with it the radionuclide to destroy the "bad" cells with its radiations. An advantage of using a nuclear reactor to produce these radionuclides is that the radiation they emit—beta radiation—cannot travel more than 1/4 inch in the body, limiting its damage to the cancerous tissue and avoiding neighboring healthy cells.

In recent years researchers at MU and MURR have focussed on a class of radioactive atoms called the radiolanthanides. These radionuclides all have very similar chemical behavior, but they have different beta radiation energies and emit their radiation at different rates. These rates are called "half lives." Because of chemical similarity, the radiolanthanides can all use the same super glue to attach to guiding biomolecules. However, some guiding biomolecules take longer than others to reach their targeted tumor sites in the body; radiolanthanides with longer half lives are best with these. On the other hand, a shorter half-life is better for guiding molecules that attach to sites of cancer quickly. The range of energy and half-life choices of the radiolanthanides, when coupled with the precise targeting ability of the biomolecule, gives great versatility for treating tumors of different types and sizes.

Often, the guiding molecules can be used in the body in only very small amounts, and each molecule can have only one radioactive atom attached to it. Thus, it is important that as high a fraction of the sample as possible be radioactive. This is called achieving a "high specific activity." MURR is one of the few reactors in the world that can supply very high specific activity radiolanthanides such as Lutetium-177, Samarium-153, and Holmium-166.


to learn about "A major success story"
return to Radiopharmaceuticals Intro continue to A major success story

MURR Introduction to the nation's premier university research reactor MURR Research and Development--R&D at the nation's premier university research reactor MURR Education--training tomorrow's nuclear scientists, engineers and technicians MURR Products and Services--providing quality nuclear products and services to a global community MURR Center homepage MURR Center homepage MURR Operations--safe and reliable University of Missouri-Columbia homepage MURR Site Map




MURR Relicensing
The reactor is in the process of relicensing for another 20 years of nuclear-based research, education and medical and other applications. Check here for project updates.





Content Copyright © 2003-2008 The Curators of the University of Missouri
DMCA and other copyright information. All rights reserved.

An equal opportunity/ADA institution.
If you would like more information or experience difficulty with any of these pages,
please contact our web editor.
Last updated August 2008